UPDATE: Goldman Sachs Downgrades Seres Therapeutics (MCRB) to Sell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to UPDATE: Goldman Sachs Downgrades Seres Therapeutics (MCRB) to Sell

Form 8-K Seres Therapeutics, Inc. For: Jul 22

July 22, 2021 7:08 AM EDT

Exhibit 99.1

 

Seres Therapeutics Announces Topline Results for SER-287 Phase 2b Study in Mild-to-Moderate Ulcerative Colitis... More